“Beyond PD-1 PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance”. 2026. Journal of Biomolecules, Pathogenesis and Therapeutics 2 (1). https://jbptjournal.org/index.php/jbpt/article/view/33.